NRC Health carries a market capitalization of 478.90M, placing it among publicly traded companies globally. Its enterprise value stands at 564.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 478.90M |
| Enterprise Value | 564.25M |
NRC Health currently has 22.14M shares outstanding.
| Shares Outstanding | 22.14M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
NRC Health trades at a trailing price-to-earnings ratio of 80.74. The price-to-sales ratio is 3.38, and the price-to-book ratio stands at 72.92.
| PE Ratio | 80.74 |
| PS Ratio | 3.38 |
| PB Ratio | 72.92 |
| P/TBV Ratio | -7.74 |
| P/FCF Ratio | 12.68 |
| P/OCF Ratio | 16.03 |
On an enterprise value basis, NRC Health trades at an EV/EBITDA multiple of 24.15 and an EV/FCF ratio of 13.85. The EV/Sales ratio of 4.03 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 38.29 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.03 |
| EV / EBITDA | 24.15 |
| EV / EBIT | 38.29 |
| EV / FCF | 13.85 |
NRC Health maintains a current ratio of 0.65, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,374.68, indicating moderate leverage, while an interest coverage ratio of 4.32 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.65 |
| Quick Ratio | 0.48 |
| Debt / Equity | 1,374.68 |
| Debt / EBITDA | 3.85 |
| Interest Coverage | 4.32 |
NRC Health posts a return on equity of 42.03 and a return on invested capital of 9.26.
| Return on Equity (ROE) | 42.03 |
| Return on Assets (ROA) | 4.22 |
| Return on Invested Capital (ROIC) | 9.26 |
| Return on Capital Employed (ROCE) | 9.29 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, NRC Health has paid 3.53M in income taxes, reflecting an effective tax rate of 37.56.
| Income Tax | 3.53M |
| Effective Tax Rate | 37.56 |
NRC Health's stock has gained approximately 44.26341% over the past 52 weeks. The 50-day moving average sits at 21.22, while the 200-day moving average is 18.51.
| Beta (5Y) | N/A |
| 52-Week Price Change | 44.26341% |
| 50-Day Moving Average | 21.22 |
| 200-Day Moving Average | 18.51 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, NRC Health generated 140.00M in revenue and converted that into 5.86M in net income, yielding earnings per share of 0.27. EBITDA reached 23.37M, while operating income came in at 14.74M.
| Revenue | 140.00M |
| Gross Profit | 86.45M |
| Operating Income | 14.74M |
| Pretax Income | 9.38M |
| Net Income | 5.86M |
| EBITDA | 23.37M |
| EBIT | 14.74M |
| Earnings Per Share (EPS) | 0.27 |
NRC Health holds 3.33M in cash and equivalents against 90.03M in total debt, resulting in a net debt position of 86.70M. Total book value stands at 6.55M, with working capital of -12.21M providing operational flexibility.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 90.03M |
| Net Debt | 86.70M |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | 0.30 |
| Working Capital | -12.21M |
NRC Health produced 29.51M in operating cash flow over the past twelve months. After subtracting -7.87M in capital expenditures, free cash flow totaled 21.64M - equivalent to 0.99 per share.
| Operating Cash Flow | 29.51M |
| Capital Expenditures | -7.87M |
| Free Cash Flow | 21.64M |
| FCF Per Share | 0.99 |
NRC Health operates with a gross margin of 61.75, reflecting its pricing power and cost economics. The operating margin of 10.53 and net profit margin of 4.19 provide insight into operational efficiency.
| Gross Margin | 61.75 |
| Operating Margin | 10.53 |
| Pretax Margin | 6.70 |
| Profit Margin | 4.19 |
| EBITDA Margin | 16.69 |
The company's payout ratio of 216.85 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.58 |
| Dividend Yield | N/A |
| Payout Ratio | 216.85 |
| Shareholder Yield | 4.94 |
| FCF Yield | 7.89 |
NRC Health posts an Altman Z-Score of 4.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.27 |